VHL and MG132

MG132 (Z-Leu-Leu-Leu-al; MG-132) | CAS 133407-8...

MG132 (Z-Leu-Leu-Leu-al; MG-132) | CAS 133407-8...

MG132 Induces Expression of Monocyte Chemotacti...

Attenuation of MG132-induced HeLa Cell Death by...

Degradation of HIF-proteins by a VHL-independen...

MG132, a proteasome inhibitor, enhances LDL upt...

Attenuation of MG132-induced HeLa Cell Death by...

TGase 2-mediated VHL depletion occurs through p...

Chronic MG132 protected against two different t...

ABL kinases regulate the stabilization of HIF-1...

The VHL protein stability is enhanced by lysine...

MG-132|Proteasome inhibitor, Cell permeable, re...

Cell viability assay of MG132-NPs and free MG13...

MG132 | CAS 133407-82-6 | LKT Laboratories | Bi...

MG-132 [133407-82-6] Clinisciences

MG-132 [133407-82-6] Clinisciences

Proteasome inhibitor MG132 inhibits the process...

MG-132|Proteasome inhibitor, Cell permeable, re...

APExBIO - MG-132|Proteasome inhibitor, Cell per...

MG132 (Z-Leu-Leu-Leu-al; MG-132) | CAS 133407-8...

MG132 reverse the malignant characteristics of ...

Volume 51, Issue 4, Pages (August 2006) - ppt d...

(A) Immunoblots showing IP with HA or VHL antib...

APExBIO - MG-132|Proteasome inhibitor, Cell per...

The effect of MG132 on compartmentalization of ...

The effect of 20 μM MG132 on cell concentration...

The association between HIF-1a to VHL or MDM2 i...

FIH-1: a novel protein that interacts with HIF-...

MG132 proteasome inhibitor upregulates the expr...

MG 132 | Proteasome | Tocris Bioscience

GFP-VHL213 forms two distinct aggregates. (A) S...

MG132-mediated inhibition of the ubiquitin–prot...

MG132 reverse the malignant characteristics of ...

MG132 (Z-Leu-Leu-Leu-al; MG-132) | CAS 133407-8...

SCG2 promotes HIF‐1α degradation via binding to...